Q. Which of the following is not an objective of bioavailability studies?

View solution

Q. Single-dose bioavailability studies are simple and common.

View solution

Q. Multiple dose study is better since we can understand the peak, valley, drug blood levels, etc.

View solution

Q. Which of the following is the pharmacodynamics method of studying bioavailability?

View solution

Q. Which of the following is not an important parameter of plasma level time studies?

View solution

Q. What is the equation for bioavailability?

View solution

Q. The urinary excretion of the unchanged drug is directly proportional to the plasma concentration of a drug.

View solution

Q. Which of the following will not be a parameter that should be examined for urinary excretion data?

View solution

Q. Which of the following is not measured in acute pharmacological response study?

View solution

Q. Therapeutic response is based on observing the clinical response to a drug formulation.

View solution

Q. In vitro determination of bioavailability by dissolution rate is not the best way to determine therapeutic efficacy.

View solution

Q. What is bioequivalence?

View solution

Q. What is the chemical equivalence?

View solution

Q. What is pharmaceutic equivalence?

View solution

Q. What is bioequivalence?

View solution

Q. What is therapeutic equivalence?

View solution

Q. On which individuals study of newly invented medicines are not done?

View solution

Q. What should be the disadvantage of cross over study on volunteers?

View solution

Q. Two or more drugs contain the same therapeutically active ingredient which elicits same pharmacological effects and can control the disease to the same extent are known to be pharmaceutic equivalent.

View solution

Q. If the bioavailability of test formulation is 80-120% of the reference standard, it is considered to be bioequivalent.

View solution